04 May 2023 | Thursday | News
Image Source : Public Domain
"Production capability and capacity, as well as logistics challenges have been major bottlenecks to radiotherapeutic discovery and development," said Philippe van Put, General Manager of Full-Life Technology Europe. "The advanced GMP manufacturing facility we are building at this 17,000 square meter site, will provide us with an internal, integrated manufacturing solution and a strong competitive advantage." He noted that Wallonia in Belgium was selected for its strategic geographic location, advanced infrastructure, and excellent transportation network.
The region is a leading hub for radiopharmaceutical production, and Full-Life will leverage its expertise and the local ecosystem to accelerate the facility's construction and GMP drug production.